INSIGHTS ON DRUG DEVELOPMENT

• Design Scalable Downstream Processes With Practical Strategies

  Downstream purification is becoming more complex as new modalities enter development. Learn how advanced analytics and chromatography strategies can support scalable, confident process development.

• Complementary Methodologies For Analysis Of NISTmAb Impurities

  Gain insight into how SEC and CE‑SDS complement each other to assess monoclonal antibody size variants, offering stronger insight into aggregates, fragments, and overall purity.

• Sensitive RNA Fluorescent Quantitation With An RNA Assay Kit

  Accurate nucleic acid quantification is vital for applications like PCR and NGS. Discover an RNA Assay Kit that offers precise RNA measurement to enhance reliability and performance in downstream assays.

• Collaboration An Untapped Fuel For Driving Biopharma R&D

  Biopharma’s future depends on collaboration. Discover how cross-industry partnerships and shared resources can accelerate innovation, overcome talent gaps, and strengthen the global R&D ecosystem.

• Strategies For The Development Of Safe And Effective Pediatric Formulations

  5/12/2025

  Medicines for infants and children face unique formulation challenges. Learn about the key considerations, including developmental physiology, age specifics, palatability, ease of administration, and precise dosing.

• High-Throughput Pyrogen Testing In A Multimode Microplate Reader

  3/20/2026

  Explore a faster, high‑sensitivity approach to pyrogen detection that uses an NF‑κB reporter system to measure both endotoxin and non‑endotoxin contaminants to enable shorter workflows.

• Optimizing Yield, Purity, And Scalability In A Cost-Effective Manner During Process Development

  7/23/2026

  Daniele Vigo, Assistant Director at Cambrex Milan, on getting yield, purity, and scalability right without burning through the budget.

• Market Dynamics Related To The Development And Commercialization Of Peptides

  7/23/2026

  Matt Bio, CSO of Cambrex and President of Snapdragon Chemistry, on the capacity bottleneck behind peptide shortages — and why moving from solid-phase to liquid-phase synthesis unlocks reactors already sitting idle around the world.

• Your AKTA Oligosynt™ System : It's More Than A Machine

  2/9/2026

  Discover how early choices in oligo synthesis workflows shape performance. Learn what to consider across design, reagents, and system optimization to build a process ready for smooth scale‑up.